Profound Medical
PROF
48 hedge funds and large institutions have $143M invested in Profound Medical in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 10 closing their positions.
36% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 14
25% more call options, than puts
Call options by funds: $2.11M | Put options by funds: $1.68M
0.12% more ownership
Funds ownership: 42.76% → 42.87% (+0.12%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 54 → 48 (-6)
18% less capital invested
Capital invested by funds: $174M → $143M (-$31.9M)
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.57M |
| 2 |
BC
Blackcrane Capital
Bellevue,
Washington
|
+$1.82M |
| 3 |
ACM
Altium Capital Management
New York
|
+$1.56M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$930K |
| 5 |
ZDA
Zweig-DiMenna Associates
New York
|
+$746K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$2.37M |
| 2 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$1.7M |
| 3 |
GIPM
G2 Investment Partners Management
New York
|
-$1.24M |
| 4 |
Renaissance Technologies
New York
|
-$1.09M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$1.09M |
PROF Hedge Fund Activity: Q2 2021 in Review
48 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q2 2021, worth a combined $143M — down 18% from $174M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of PROF and 4 opened new positions — a net loss of 6 holders — while 14 trimmed existing stakes and 19 added.
The largest buyer was Royal Bank of Canada, adding an estimated $4.57M. The largest seller was Pura Vida Investments, cutting an estimated $2.37M.
- 48 institutional investors held Profound Medical (PROF) as of Q2 2021, down from 54 in Q1 2021.
- Funds reported $143M of Profound Medical stock for Q2 2021, down 18% quarter-over-quarter.
- 4 funds opened new Profound Medical positions in Q2 2021 and 10 closed out, a net change of -6 holders.
- The largest Profound Medical buyer in Q2 2021 was Royal Bank of Canada, an estimated $4.57M added.
- The largest Profound Medical seller in Q2 2021 was Pura Vida Investments, an estimated $2.37M sold.
Based on aggregated 13F filings for Q2 2021.